Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Nita Ahuja

Nita Ahuja, M.D.

Director of Sarcoma and Peritoneal Surface Malignancy Program
Associate Professor of Surgery

Female

Appointment Phone

443-997-1508

Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Director of Sarcoma and Peritoneal Surface Malignancy Program
  • Chief, Mixed Tumor Services
  • Associate Professor of Surgery
  • Associate Professor of Oncology
  • Associate Professor of Urology

Centers & Institutes

Departments

  • Oncology - Cancer Biology
  • Surgery - Surgical Oncology
  • Urology

Locations

The Johns Hopkins Hospital

Appointment Phone: 443-997-1508

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-955-5020
Fax: 443-451-8583

Expertise

Colorectal Cancer, Cytoreductive Surgery, Gastric Cancer, Gastroesophageal Cancer, Gastroesophageal Junction Cancer, Gastrointestinal Cancers, General Surgery, GIST, Intraperitoneal Chemotherapy, Neuroendocrine Tumors, Pancreatic Cancer, Retroperitoneal Sarcomas, Sarcoma, Stomach Cancer, Stomach Tumors, Whipple Procedure

Biography

Dr. Nita Ahuja is an associate professor of urology, surgery and oncology at the Johns Hopkins School of Medicine. Her surgical specialization is in gastrointestinal cancers, including gastric, rectal and pancreatic cancers.

Dr. Ahuja serves as the Director of Sarcoma and Peritoneal Surface Malignancy Program and the Chief of Mixed Tumor Services.

Dr. Ahuja obtained her medical education at the Duke University School of Medicine and her training in general surgery at Johns Hopkins. In addition, she completed a fellowship in surgical oncology at Johns Hopkins focused on hepatobiliary malignancies. Dr. Ahuja joined the Johns Hopkins faculty in 2003.

Dr. Ahuja also directs an active cancer research laboratory studying molecular markers important in early diagnosis and prognosis of gastrointestinal cancer.

Dr. Ahuja was certified in surgery by the American Board of Surgery in 2003.

...read more

Featured Video

Johns Hopkins Surgical Oncologists Get Personal

More Videos

    Additional Information

  • Education +

    Degrees

    • Duke University School of Medicine / MD (1993)

    Residencies

    • Johns Hopkins University School of Medicine / Surgery (2002)

    Certifications

    • American Board of Surgery / Surgery (2003, 2024)
  • Research & Publications +

    Clinical Trials:

    Partial Breast Irradiation With Concurrent Chemotherapy for Women With Breast Cancer (PBI 3)


    Selected Publications

    1. Downing, S.R.; Datoo, G.; Oyetunji, T.A.; Fullum, T.; Chang, D.C.; Ahuja, N. "Asian race/ethnicity as a risk factor for bile duct injury during cholecystectomy." Arch Surg. 2010 Aug;145(8):785-787.
    2. Hayanga, A.J.; Mukherjee, D.; Chang, D.; Kaiser, H.; Lee, T.; Gearhart, S.; Ahuja, N.; Freischlag, J. "Teaching hospital status and operative mortality in the United States: tipping point in the volume-outcome relationship following colon resections?" Arch Surg. 2010 Apr;145(4):346-350
    3. Poultsides, G.A.; Reddy, S.; Cameron, J.L.; Hruban, R.H.; Pawlik, T.M.; Ahuja, N.; Jain, A.; Edil, B.H.; Iacobuzio-Donahue, C.A.; Schulick, R.D.; Wolfgang, C.L. "Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas." Ann Surg. 2010 Mar;251(3):470-476.
    4. Stojadinovic, A.; Ahuja, N.; Nazarian, S.M.; Segev, D.L.; Jacobs, L.; Wang, Y.; Eberhardt, J.; Zeiger, M.A. "Translational research in surgical disease." Arch Surg. 2010 Feb;145(2):187-196.
    5. van Vlodrop, I.J.; Baldewijns, M.M.; Smits, K.M.; Schouten, L.J.; van Neste, L.; van Criekinge, W.; van Poppel, H.; Lerut, E.; Schuebel, K.E.; Ahuja, N.; Herman, J.G.; de Bruine, A.P.; van Engeland, M. "Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma." Am J Pathol. 2010 Feb;176(2):575-584.
  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    • $50,000 grant, from Abell Foundation for development of blood test for early detection of pancreatic cancer , 2014
  • Videos & Media +

    Videos

    Surgical Oncologist, Nita Ahuja, M.D. Discusses Sarcoma

    Importance of Sarcoma Surgery Done Right The First Time

    Sarcoma Treatment | Nora's Story

    Sarcoma (Soft Tissue Cancer) Treatment | Nora's Story (Extended version)

Is This You? Edit Profile
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.